Inactive Instrument

Press Releases Cellect Biotechnology Ltd

Equities

IL0002410186

End-of-day quote TEL AVIV STOCK EXCHANGE Other stock markets
- ^ILa	-

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cellect Biotechnology Ltd : Provides Corporate Update and Reports First Quarter 2017 Financial Results	17-05-29	PR
Cellect Gets Green Light From FDA For ApoGraft IND Submission in the U.S.	17-05-03	GL
Cellect Receives Notice of Intention to Grant from European Patent Office for Patent Protecting Company’s Technology in Multiple Indications	17-04-03	GL
Cellect Biotechnology : Successful First Cancer Patient Stem Cell Transplant	17-03-27	PU
Cellect Announces Successful First Cancer Patient Stem Cell Transplant	17-03-27	GL
Cellect Biotechnology : Provides Corporate Update and Reports Fourth Quarter and Full Year 2016 Financial Results	17-03-27	PU
Cellect Biotechnology : Michael Berelowitz MD., Former Head, Clinical Development and Medical Affairs, Pfizer Specialty Care Business Unit Joins Cellect’s Board of Directors	17-03-27	PU
Cellect Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2016 Financial Results	17-03-23	GL
Michael Berelowitz MD., Former Head, Clinical Development and Medical Affairs, Pfizer Specialty Care Business Unit Joins Cellect’s Board of Directors	17-03-02	GL
Cellect Biotechnology : Announces Positive Clinical Trial Results	17-02-27	PU
Cellect to Ring the NASDAQ Stock Market Opening Bell on Friday, February 24th	17-02-23	GL
World-Renowned Stem Cell Transplantation Expert joins Cellect’s Advisory Board	17-02-23	GL
Cellect Announces Positive Clinical Trial Results	17-02-21	GL
Cellect Biotechnology : First Cancer Patient Treated In Phase I/II Trial Management expects additional positive upcoming results from its trial in healthy volunteers	17-02-17	PU
Cellect Biotechnology : Dual-Listed Cellect to Voluntarily File for Delisting from Tel Aviv Stock Exchange Company’s Shares to Continue Trading Only on NASDAQ Stock Exchange in US	17-02-17	PU
Dual-Listed Cellect to Voluntarily File for Delisting from Tel Aviv Stock Exchange	17-02-14	GL
Dr. Yaron Pereg Appointed as New Chief Development Officer	17-01-30	GL
Cellect Receives Patent Notice of Allowance from US Patent & Trademark Office Protecting Company’s Technology in Multiple Key Indications	17-01-12	GL
Major Shareholder Buying Shares	17-01-09	GL
Cellect Announces Appointment of Eyal Leibovitz, Experienced Life Sciences Industry and Financial Executive, as Chief Financial Officer	17-01-03	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Cellect Biotechnology Ltd

Equities

IL0002410186

Press Releases

Filters